Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PC1 | Ann: Removal from Official List - Annual Listing Fees | 16/12/20 | 10 | 25K | |||
|
|||||||
PC1 | Ann: Suspension from Official Quotation - Annual Listing Fee | 24/08/19 | 6 | 4.1K | |||
|
|||||||
PC1 | Ann: Appointment of New Director & Secretary | 13/08/19 | 11 | 8.1K | |||
|
|||||||
PC1 | Ann: Initial Director's Interest Notice | 10/07/19 | 0 | 1.1K | |||
|
|||||||
PC1 | Whos the broker that runs PC1 | 02/07/19 | 15 | 8.7K | |||
|
|||||||
PC1 | Ann: Final Director's Interest Notice | 26/05/19 | 3 | 2.2K | |||
|
|||||||
PC1 | Ann: Resignation of Director | 24/05/19 | 0 | 1.1K | |||
|
|||||||
PC1 | Ann: Initial Director's Interest Notice | 13/05/19 | 13 | 5.6K | |||
|
See All Discussions